Traditional Chinese medicinal composition specially used for treating hyperosteogeny

Abstract

The invention relates to the technical field of medicines, and concretely relates to a traditional Chinese medicinal composition specially used for treating hyperosteogeny. The traditional Chinese medicinal composition is prepared from, by weight, 10-20 parts of Chinese angelica, 8-12 parts of borneol, 10-20 parts of Rheum officinale, 20-30 parts of Poria cocos, 10-20 parts of cinnamon, 10-16 parts of musk, 6-12 parts of Corn Cervi Pantotrichum, 8-15 parts of Carapax Testudinis, 10-18 parts of Chinese Taxillus Twig, 15-25 parts of rhizome of Whiteback Greenbrier, 10-30 parts of Ligusticum wallichii, 10-30 parts of prepared rehmannia root, 20-30 parts of wolfberry fruit and 10-15 parts of unprepared rehmannia root. The purpose of the invention is to provide the traditional Chinese medicinal composition specially used for treating hyperosteogeny, with the advantages of convenient administration and no toxic side effects.

Description

technical field [0001] The invention relates to the technical field of medical products, in particular to a traditional Chinese medicine composition for treating hyperosteogeny. Background technique [0002] Osteoarthritis is currently one of the most common bone and joint diseases. Bone spurs in the bone joints cause numbness and pain in the hands and feet, difficulty in walking, neck and lumbar spine pain, sciatic nerve pain, headache, etc. This disease is mostly caused by the deficiency of liver and kidney true yin, and the lack of nourishment of muscles and bones causes deformation, swelling, and long bone spurs; the so-called "true yin" is what is called "sclerosin" collagen fibers in modern medicine. Or the joints caused by trauma and blood stasis caused by qi stagnation and blood stasis cause deformation, swelling, and long bone spurs. At present, patients with severe bone hyperplasia are treated with surgery, but the cost is high, the safety is poor and recurrence i...

AI Technical Summary

Problems solved by technology

Surgical treatment is currently used for patients with severe bone hyperplasia, but the cost is high, the safety is poor and recurrence is easy

Although there are some Chinese patent medicines for the treatment of hyperosteogeny in traditional Chinese medicine, the treatment time is long, the curative effect is poor, the cost is high, and the desired effect cannot be achieved.